Mylan NV (NASDAQ:MYL)

17.53
Delayed Data
As of Nov 12
 +0.29 / +1.68%
Today’s Change
16.63
Today|||52-Week Range
36.94
-36.02%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$9.1B

Company Description

Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.

Contact Information

Mylan NV
Building 4
Hatfield Hertfordshire AL10 9UL
P:441707853000
Investor Relations:

Employees

Shareholders

Mutual fund holders51.49%
Individual stakeholders5.76%
Other institutional35.98%

Top Executives

There are no executives to display.